Document is current
Any future updates will be listed below
-
Authors
Chen, Xinhong http://orcid.org/0000-0003-0408-0813
Wolfe, Damien A.
Bindu, Dhanesh Sivadasan
Zhang, Mengying
Taskin, Naz
Goertsen, David http://orcid.org/0000-0001-7138-1697
Shay, Timothy F. http://orcid.org/0000-0001-6591-3271
Sullivan, Erin E. http://orcid.org/0000-0002-1724-6520
Huang, Sheng-Fu
Ravindra Kumar, Sripriya http://orcid.org/0000-0001-6033-7631
Arokiaraj, Cynthia M. http://orcid.org/0000-0003-3201-9868
Plattner, Viktor M. http://orcid.org/0000-0002-0740-2905
Campos, Lillian J. http://orcid.org/0000-0003-0839-0288
Mich, John K.
Monet, Deja
Ngo, Victoria
Ding, Xiaozhe http://orcid.org/0000-0002-0267-0791
Omstead, Victoria
Weed, Natalie
Bishaw, Yeme
Gore, Bryan B. http://orcid.org/0000-0003-1721-4235
Lein, Ed S. http://orcid.org/0000-0001-9012-6552
Akrami, Athena http://orcid.org/0000-0001-5711-0903
Miller, Cory
Levi, Boaz P. http://orcid.org/0000-0002-8346-872X
Keller, Annika http://orcid.org/0000-0003-1466-3633
Ting, Jonathan T.
Fox, Andrew S. http://orcid.org/0000-0003-0695-3323
Eroglu, Cagla http://orcid.org/0000-0002-7204-0218
Gradinaru, Viviana http://orcid.org/0000-0001-5868-348X
- License Information
-
More Information
Article History
Received: 18 February 2023
Accepted: 2 May 2023
First Online: 8 June 2023
Competing interests
: The California Institute of Technology has one patent pending for the sequences described in this manuscript, with X.C. and V.G. listed as inventors (PCT Patent Application No: PCT/US2022/027516). V.G. is a co-founder and board member of Capsida Biotherapeutics, a fully integrated AAV engineering and gene therapy company. The remaining authors declare no competing interests.
